Lucie‐Marie Scailteux

French administrative health care database (SNDS): The value of its enrichment

Lucie‐Marie Scailteux, C. Droitcourt, Frédéric Balusson et al. · Therapies · 2018 · 117 citations · Full text

Health Administration, Nursing, Primary Care +8

Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists—a nationwide population-based cohort study based on 2010–2013 French Health Insurance data

Lucie‐Marie Scailteux, S. Vincendeau, Frédéric Balusson et al. · European Journal of Cancer · 2017 · 56 citations

Hormonal Contraceptive, Cardiovascular Epidemiology, Cardiovascular Disease +10

Risk of cardiovascular disease following gonadotropin‐releasing hormone agonists vs antagonists in prostate cancer: Real‐world evidence from five databases

Gincy George, Hans Garmo, Lucie‐Marie Scailteux et al. · International Journal of Cancer · 2020 · 38 citations · Full text

Overall Survival Among Chemotherapy-Naive Patients With Castration-Resistant Prostate Cancer Under Abiraterone Versus Enzalutamide: A Direct Comparison Based on a 2014–2018 French Population Study (the SPEAR Cohort)

Lucie‐Marie Scailteux, Boris Campillo‐Gimenez, Sandrine Kerbrat et al. · American Journal of Epidemiology · 2020 · 32 citations · Full text

Cancer Management, Cancer Registration, Pharmacotherapy +19

Urologic Disorders are Still the Leading Cause of In-hospital Death in Patients With Spina Bifida

B. Peyronnet, Fei Gao, Charlène Brochard et al. · Urology · 2019 · 26 citations · Full text

Urological Research, Urology, In-hospital Death +6